Vor Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	119	153	257	433	-	-	-
Market Cap Growth	-	-40.67%	-40.66%	-	-	-	-
Enterprise Value	15	49	63	241	-32	-8	4
PE Ratio	-1.29	-1.29	-2.79	-6.18	-	-	-
PB Ratio	0.79	1.01	1.03	2.00	-	-	-
P/FCF Ratio	-1.51	-1.51	-2.75	-5.93	-	-	-
P/OCF Ratio	-1.52	-1.52	-3.02	-6.27	-	-	-
EV/EBITDA Ratio	-0.44	-0.44	-0.74	-3.75	0.76	0.79	-1.13
EV/EBIT Ratio	-0.41	-0.41	-0.69	-3.50	0.73	0.78	-1.12
EV/FCF Ratio	-0.48	-0.48	-0.68	-3.31	0.79	0.76	-1.33
Debt / Equity Ratio	0.24	0.24	0.16	0.08	-0.31	-	-0.66
Debt / EBITDA Ratio	-0.33	-0.33	-0.45	-0.28	-0.44	-	-1.43
Debt / FCF Ratio	-0.35	-0.35	-0.42	-0.25	-0.45	-	-1.68
Quick Ratio	8.96	8.96	17.73	20.67	4.91	3.67	0.12
Current Ratio	9.04	9.04	18.06	21.12	4.81	3.45	0.12
Interest Coverage	-	-	-	-	-	-16.83	-3.14
Return on Equity (ROE)	-62.00%	-62.00%	-47.30%	-29.00%	128.80%	104.20%	-
Return on Assets (ROA)	-49.60%	-49.60%	-38.20%	-26.20%	-114.90%	-232.80%	-
Return on Capital (ROIC)	-67.62%	-67.62%	-32.27%	-29.46%	106.36%	59.77%	123.81%
Earnings Yield	-99.30%	-77.26%	-35.82%	-16.18%	-	-	-
FCF Yield	-85.40%	-66.44%	-36.40%	-16.86%	-	-	-
Buyback Yield / Dilution	-69.89%	-69.89%	-18.30%	-15548.00%	86.33%	-30.97%	-
Total Shareholder Return	-69.89%	-69.89%	-18.30%	-15548.00%	86.33%	-30.97%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).